Immunic (10V) Stock Forecast & Price Target
10V Analyst Ratings
Strong Buy
11Buy0Hold0Sell
Based on 11 analysts giving stock ratings to Immunic in the past 3 months
10V Stock 12 Month Forecast
Average Price Target
EUR 32.64▲(373.85% Upside)Based on 11 Wall Street analysts offering 12 month price targets for Immunic in the last 3 months. The average price target is EUR 32.64 with a high forecast of EUR 62.50 and a low forecast of EUR 19.64. The average price target represents a 373.85% change from the last price of EUR 6.89.
Past 12 Months12 Month ForecastDec2025Sep2026
HighEUR 62.50
AverageEUR 32.64
LowEUR 19.64
Highest Price TargetHighestEUR 62.50Average Price TargetEUR 32.64Lowest Price TargetLowestEUR 19.64
Detailed List of Analyst Forecasts
Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| Paul Matteis | Stifel Nicolaus | EUR 22.32 | buy | 224.06%Upside | Reiterated | 10/30/26 | ||
| Yanni Souroutzidis | Cantor Fitzgerald | EUR 26.79 | buy | 288.87%Upside | Initiated | 10/23/26 | ||
| Matthew Caufield | H.C. Wainwright | EUR 19.64 | buy | 185.17%Upside | Reiterated | 10/22/26 | ||
| Sam Slutsky | LifeSci Capital | EUR 50.00 | buy | 625.89%Upside | Reiterated | 09/11/26 | ||
| Myles Minter | William Blair | ― | buy | ― | Reiterated | 09/10/26 | ||
 Unknown AnalystNot Ranked | Leerink Partners | ― | buy | ― | Reiterated | 09/10/26 | ||
| Martin Fan | Wedbush | EUR 40.18 | buy | 483.31%Upside | Reiterated | 09/10/26 | ||
| William Wood | B. Riley Securities | EUR 24.11 | buy | 249.98%Upside | Reiterated | 09/02/26 | ||
| Boobalan Pachaiyappan | Roth MKM | EUR 16.96→EUR 25.89 | buy | 275.91%Upside | Reiterated | 09/01/26 | ||
| Yatin Suneja | Guggenheim | EUR 62.50 | buy | 807.37%Upside | Reiterated | 08/11/26 | ||
| Rudy Li | Wolfe Research | EUR 22.32 | buy | 224.06%Upside | Reiterated | 08/11/26 | ||
| Jason Kolbert | D. Boral Capital | ― | hold | ― | Downgraded | 04/15/26 |
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| Paul Matteis | 10/30/26 | EUR 22.32 | buy | 224.06%Upside | Reiterated | Stifel Nicolaus | ||
| Yanni Souroutzidis | 10/23/26 | EUR 26.79 | buy | 288.87%Upside | Initiated | Cantor Fitzgerald | ||
| Matthew Caufield | 10/22/26 | EUR 19.64 | buy | 185.17%Upside | Reiterated | H.C. Wainwright | ||
| Sam Slutsky | 09/11/26 | EUR 50.00 | buy | 625.89%Upside | Reiterated | LifeSci Capital | ||
| Myles Minter | 09/10/26 | ― | buy | ― | Reiterated | William Blair | ||
| Unknown AnalystNot Ranked | 09/10/26 | ― | buy | ― | Reiterated | Leerink Partners | ||
| Martin Fan | 09/10/26 | EUR 40.18 | buy | 483.31%Upside | Reiterated | Wedbush | ||
| William Wood | 09/02/26 | EUR 24.11 | buy | 249.98%Upside | Reiterated | B. Riley Securities | ||
| Boobalan Pachaiyappan | 09/01/26 | EUR 16.96→EUR 25.89 | buy | 275.91%Upside | Reiterated | Roth MKM | ||
| Yatin Suneja | 08/11/26 | EUR 62.50 | buy | 807.37%Upside | Reiterated | Guggenheim | ||
| Rudy Li | 08/11/26 | EUR 22.32 | buy | 224.06%Upside | Reiterated | Wolfe Research | ||
| Jason Kolbert | 04/15/26 | ― | hold | ― | Downgraded | D. Boral Capital |
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Best Analysts Covering Immunic
3 Months
Success Rate7/13 ratings generated profit
54%
Average Return
+19.25%
Copying Myles Minter's trades and holding each position for 3 Months would result in 53.85% of your transactions generating a profit, with an average return of +19.25% per trade.
1 Year
Success Rate7/13 ratings generated profit
54%
Average Return
>-0.01%
Copying Myles Minter's trades and holding each position for 1 Year would result in 53.85% of your transactions generating a profit, with an average return of >-0.01% per trade.
2 Years
Success Rate4/13 ratings generated profit
31%
Average Return
-13.47%
Copying Myles Minter's trades and holding each position for 2 Years would result in 30.77% of your transactions generating a profit, with an average return of -13.47% per trade.
10V Analyst Recommendation Trends
| Rating | May 26 | Jun 26 | Jul 26 | Aug 26 | Sep 26 |
|---|---|---|---|---|---|
| Strong Buy | 13 | 11 | 5 | 10 | 14 |
| Buy | 2 | 1 | 2 | 4 | 4 |
| Hold | 1 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 16 | 12 | 7 | 14 | 18 |
In the current month, 10V has received 18 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. 10V average Analyst price target in the past 3 months is 32.64.
10V Financial Forecast
ConsensusEUR 0.00
10V Sales Forecast
Next quarter’s sales forecast for 10V is EUR 0 with a range of ― to ―. The previous quarter’s sales results were EUR 0. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.
10V Stock Forecast FAQ
What is DE:10V’s average 12-month price target, according to analysts?
Based on analyst ratings, Immunic’s 12-month average price target is €32.64.
What is DE:10V’s upside potential, based on the analysts’ average price target?
Immunic has 373.85% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Immunic a Buy, Sell or Hold?
Immunic has a consensus rating of Strong Buy, which is based on 11 buy ratings, 0 hold ratings and 0 sell ratings.
What is Immunic’s share price target?
The average share price target for Immunic is €32.64. This is based on 11 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is €62.50, and the lowest forecast is €19.64. The average share price target represents a 373.85% increase from the current price of €6.888.
What do analysts say about Immunic?
Immunic’s analyst rating consensus is a Strong Buy. This is based on the ratings of 11 Wall Street analysts.
How can I buy shares of Immunic?
To buy shares of DE:10V, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.